Cargando…

Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529244/
https://www.ncbi.nlm.nih.gov/pubmed/26252715
http://dx.doi.org/10.1371/journal.pone.0135547
_version_ 1782384769475018752
collection PubMed
description
format Online
Article
Text
id pubmed-4529244
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45292442015-08-12 Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients PLoS One Correction Public Library of Science 2015-08-07 /pmc/articles/PMC4529244/ /pubmed/26252715 http://dx.doi.org/10.1371/journal.pone.0135547 Text en © 2015 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
title Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
title_full Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
title_fullStr Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
title_full_unstemmed Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
title_short Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients
title_sort correction: a lead-in with silibinin prior to triple-therapy translates into favorable treatment outcomes in difficult-to-treat hiv/hepatitis c coinfected patients
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529244/
https://www.ncbi.nlm.nih.gov/pubmed/26252715
http://dx.doi.org/10.1371/journal.pone.0135547
work_keys_str_mv AT correctionaleadinwithsilibininpriortotripletherapytranslatesintofavorabletreatmentoutcomesindifficulttotreathivhepatitisccoinfectedpatients